FDA Announces New Date for Patient-Focused Drug Development Meeting on Stimulant Use Disorder

Summary

The Food and Drug Administration (FDA) is requesting public comments on a new virtual meeting date for a patient-focused discussion on stimulant use disorder treatment approaches, following the cancellation of an original meeting scheduled for March 10, 2020.